Markets

Market

News Details

(15/05/2025 20:30)

Alivus Life Sciences Q4 net profit jumps 44.85% at Rs 141.87 cr

The company reported standalone net profit of Rs 141.87 crore for the quarter ended March 31, 2025 as compared to Rs 97.94 crore in the same period last year, registering a year-on-year growth of 44.85 per cent.

Net revenue of the company rose substantially by 21.05 per cent at Rs 649.55 crore in January-March quarter of this fiscal as against Rs 536.60 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 14.16 per cent to Rs 451.11 crore from Rs 395.15 crore in year ago period.

Other Income grew by 222.36 per cent at Rs 10.09 crore versus (Mar'24 Rs 3.13 crore).

Operating Profit surged by 40.28 per cent to Rs 198.43 crore as against Rs 141.45 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 15.90 per cent in March quarter.

Interest grew by 250.00 per cent y-o-y to Rs 1.26 crore, while Taxation increased by 55.70 per cent at Rs 49.42 crore (Mar'24 Rs 31.74 crore).